<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58321</article-id><article-id pub-id-type="doi">10.7554/eLife.58321</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Dopamine promotes instrumental motivation, but reduces reward-related vigour</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-185256"><name><surname>Grogan</surname><given-names>John P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0463-8904</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186488"><name><surname>Sandhu</surname><given-names>Timothy R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186487"><name><surname>Hu</surname><given-names>Michele T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-71805"><name><surname>Manohar</surname><given-names>Sanjay G</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0735-4349</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Nuffield Department of Clinical Neuroscience</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Department of Psychology</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Nuffield Department of Clinical Neurosciences</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-144348"><name><surname>Flagel</surname><given-names>Shelly B</given-names></name><role>Reviewing editor</role><aff><institution>University of Michigan</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>john.grogan@ndcn.ox.ac.uk</email> (JG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>10</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e58321</elocation-id><history><date date-type="received"><day>27</day><month>04</month><year>2020</year></date><date date-type="accepted"><day>30</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Grogan et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Grogan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58321-v1.pdf"/><abstract><p>We can be motivated when reward depends on performance, or merely by the prospect of a guaranteed reward. Performance-dependent (contingent) reward is instrumental, relying on an internal action-outcome model, whereas motivation by guaranteed reward may minimise opportunity cost in reward-rich environments. Competing theories propose that each type of motivation should be dependent on dopaminergic activity. We contrasted these two types of motivation with a rewarded saccade task, in patients with Parkinson’s disease (PD). When PD patients were ON dopamine, they had greater response vigour (peak saccadic velocity residuals) for <italic>contingent</italic> rewards, whereas when PD patients were OFF medication, they had greater vigour for <italic>guaranteed</italic> rewards. These results support the view that reward expectation and contingency drive distinct motivational processes, and can be dissociated by manipulating dopaminergic activity. We posit that dopamine promotes goal-directed motivation, but dampens reward-driven vigour, contradictory to the prediction that increased tonic dopamine amplifies reward expectation</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>MRC</institution></institution-wrap></funding-source><award-id>MR/P00878X</award-id><principal-award-recipient><name><surname>Manohar</surname><given-names>Sanjay G</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Michele T Hu, MTH is a consultant advisor to the Roche Prodromal Advisory, Biogen Digital Advisory Board, Evidera, and CuraSen Therapeutics, Inc..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Ethical approval was granted by the South Central Oxford A REC (18/SC/0448). All participants gave written informed consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Anonymised data are available on OSF (https://osf.io/2k6x3)</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Grogan JP</collab><collab>Sandhu TR</collab><collab>Hu MT</collab><collab>Manohar SG</collab></person-group><year iso-8601-date="2020">2020</year><source>Contingent Motivation in PD</source><ext-link ext-link-type="uri" xlink:href="https://osf.io/2k6x3">https://osf.io/2k6x3</ext-link><comment>OSF, 2k6x3</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-58321-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>